Kyobo Life arbitration favors GPs, but resolution still elusive
A private equity consortium's right to enforce a put option against the chairman of Korea's Kyobo Life Insurance has been upheld following arbitration, though the ruling stopped short of endorsing a price for the transaction.
Both sides claimed the process – run by the International Chamber of Commerce (ICC) – represented a victory, but the impasse remains some distance, and perhaps several years, away from a resolution....
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.